GGrantIndex
← Leaderboards

National Bureau Of Economic Research

Cambridge, MA

Compare ↔
$284,619,530
Total funding
260
Grants

Funding over time

peak $23.6M · FY2005–25
$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$262,712,346 · 252
AHRQ$21,019,047 · 7
CDC$888,137 · 1

By mechanism

R01$111,150,110 · 80
P01$66,672,257 · 66
P30$25,110,095 · 38
U19$19,809,244 · 1
RC2$11,476,770 · 1
R37$11,444,663 · 2

Investigators at National Bureau Of Economic Research

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Joseph Shapiro$2,440,9311 gr2Jason Abaluck$1,383,2251 gr3Melissa Wasserman$471,7641 gr4Yunan Ji$318,4161 gr

Emerging Leaders

6–10 yrs in

1Randall K. Q. Akee$2,498,2321 gr2Tatyana Deryugina$1,627,0261 gr3Anne Case$961,8661 gr4Nikhil Agarwal$436,7701 gr5Katherine Grooms$203,2221 gr6Rebecca Dizon-Ross$145,4361 gr7Manasi Deshpande$145,4361 gr8Charles Courtemanche$99,2381 gr

All-Time

Most funded here, all years

1Amy N. Finkelstein$24,282,9348 gr2James J Heckman$17,947,45510 gr3Eileen M. Crimmins$14,062,67416 gr4Katherine Baicker$11,773,5304 gr5Axel H Boersch-Supan$9,047,2018 gr6David M Cutler$7,795,4796 gr7Angus S. Deaton$5,585,4884 gr8Alan M Garber$5,226,8884 gr

Largest grants

The Effect of Health Insurance on Utilization and Outcomes: The Oregon Lottery$5,773,334
RC2 · FY2009 · AG
The Effect of Health Insurance on Utilization and Outcomes: The Oregon Lottery$5,703,436
RC2 · FY2010 · AG
Measuring the Clinical and Economic Outcomes Associated with Delivery Systems$3,492,100
U19 · FY2015 · HS
Measuring the Clinical and Economic Outcomes Associated with Delivery Systems$3,492,100
U19 · FY2017 · HS
Measuring the Clinical and Economic Outcomes Associated with Delivery Systems$3,492,100
U19 · FY2016 · HS
Measuring the Clinical and Economic Outcomes Associated with Delivery Systems$3,492,100
U19 · FY2019 · HS
Measuring the Clinical and Economic Outcomes Associated with Delivery Systems$3,492,100
U19 · FY2018 · HS
ECONOMICS OF AGING$3,400,997
P01 · FY2000 · AG
Understanding and Improving Healthcare Decision-Making and Outcomes for People Living with Alzheimer's Disease and Related Dementias$3,185,633
P01 · FY2024 · AG
Understanding and Improving Healthcare Decision-Making and Outcomes for People Living with Alzheimer's Disease and Related Dementias$3,121,921
P01 · FY2025 · AG
NBER Coordinating Center on the Economics of AD/ADRD Prevention, Treatment, and Care.$2,929,176
U54 · FY2024 · AG
NBER Coordinating Center on the Economics of AD/ADRD Prevention, Treatment, and Care.$2,906,646
U54 · FY2025 · AG
Early Indicators of Later Work Levels, Disease and Death$2,598,321
P01 · FY2011 · AG
Economics of Aging$2,562,155
P01 · FY2007 · AG
Early Indicators of Later Work Levels, Disease and Death$2,561,515
P01 · FY2012 · AG
Economics of Aging$2,513,990
P01 · FY2006 · AG
Early Indicators of Later Work Levels, Disease and Death$2,392,308
P01 · FY2013 · AG
PA-20-072, Measuring the Clinical and Economic Outcomes Associated with Delivery Systems: "Are Health Systems Better at Responding to Pandemics?"$2,348,744
U19 · FY2021 · HS
Economics of Aging$2,309,622
P01 · FY2008 · AG
Economics of Aging$2,277,263
P01 · FY2005 · AG